4th Quarter - Report

KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 27, the Preserve Access to Affordable Generics Act

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 27 (112th)

Labor Issues/Antitrust/Workplace LBR

S. 27, the Preserve Access to Affordable Generics Act

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 27 (112th)

Copyright/Patent/Trademark CPT

S. 23, the America Invents Act of 2011 H.R. 1249, the America Invents Act of 2011

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

LobbyistCovered position, as disclosed
KEVIN MCGUINESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.